METASTATIC BLADDER CANCER
Clinical trials for METASTATIC BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC BLADDER CANCER trials appear
Sign up with your email to follow new studies for METASTATIC BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for tough bladder cancers
Disease control OngoingThis study is testing whether adding a newer immunotherapy drug (atezolizumab) to standard chemotherapy (gemcitabine and cisplatin) is safe and effective for bladder cancer. It involves two groups of patients: those with cancer that has spread (metastatic) and those with cancer t…
Matched conditions: METASTATIC BLADDER CANCER
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Simple blood test could open lifesaving cancer drug to more patients
Diagnosis OngoingThis study is testing whether a blood test can more accurately identify patients with advanced bladder cancer who are eligible for a targeted drug called erdafitinib. Currently, doctors use a tissue sample from a past biopsy, which may not reflect the current state of the cancer.…
Matched conditions: METASTATIC BLADDER CANCER
Sponsor: Bernie Eigl • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC